173 related articles for article (PubMed ID: 28437544)
21. Comparison of beta blocker and digoxin alone and in combination for management of patients with atrial fibrillation and heart failure.
Fauchier L; Grimard C; Pierre B; Nonin E; Gorin L; Rauzy B; Cosnay P; Babuty D; Charbonnier B
Am J Cardiol; 2009 Jan; 103(2):248-54. PubMed ID: 19121446
[TBL] [Abstract][Full Text] [Related]
22. Intravenous diltiazem is superior to intravenous amiodarone or digoxin for achieving ventricular rate control in patients with acute uncomplicated atrial fibrillation.
Siu CW; Lau CP; Lee WL; Lam KF; Tse HF
Crit Care Med; 2009 Jul; 37(7):2174-9; quiz 2180. PubMed ID: 19487941
[TBL] [Abstract][Full Text] [Related]
23. Anticoagulation Therapy and NOACs in Heart Failure.
Thomas I; EncisoSilva J; Schlueter M; Greenberg B
Handb Exp Pharmacol; 2017; 243():515-535. PubMed ID: 28233177
[TBL] [Abstract][Full Text] [Related]
24. Left ventricular performance during acute rate control in atrial fibrillation: the importance of heart rate and agent used.
Pinter A; Dorian P; Paquette M; Ng A; Burns M; Spanu I; Freeman M; Korley V; Newman D
J Cardiovasc Pharmacol Ther; 2003 Mar; 8(1):17-24. PubMed ID: 12652326
[TBL] [Abstract][Full Text] [Related]
25. [Not Available].
Oldgren J
Lakartidningen; 2018 Dec; 115():. PubMed ID: 30512140
[No Abstract] [Full Text] [Related]
26. Anti-Xa activity in oral factor Xa inhibitor-treated patients with atrial fibrillation and a higher risk of bleeding: a pilot study.
Samoš M; Bolek T; Stančiaková L; Škorňová I; Bánovčin P; Kovář F; Staško J; Galajda P; Kubisz P; Mokáň M
Blood Coagul Fibrinolysis; 2018 Jun; 29(4):369-373. PubMed ID: 29538002
[TBL] [Abstract][Full Text] [Related]
27. Successful resolution with apixaban of a massive left atrial appendage thrombus due to nonrheumatic atrial fibrillation: A case report and review.
Ghalyoun BA; Lempel M; Shaaban H; Shamoon F
Ann Card Anaesth; 2018; 21(1):76-77. PubMed ID: 29336400
[TBL] [Abstract][Full Text] [Related]
28. Long-term drug use and polypharmacy among the elderly population in the Republic of Srpska, Bosnia and Herzegovina.
Marković-Peković V; Škrbić R
Vojnosanit Pregl; 2016 May; 73(5):435-41. PubMed ID: 27430107
[TBL] [Abstract][Full Text] [Related]
29. Apixaban versus Antiplatelet drugs or no antithrombotic drugs after anticoagulation-associated intraCerebral HaEmorrhage in patients with Atrial Fibrillation (APACHE-AF): study protocol for a randomised controlled trial.
van Nieuwenhuizen KM; van der Worp HB; Algra A; Kappelle LJ; Rinkel GJ; van Gelder IC; Schutgens RE; Klijn CJ;
Trials; 2015 Sep; 16():393. PubMed ID: 26340977
[TBL] [Abstract][Full Text] [Related]
30. Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: a retrospective analysis of the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF).
Washam JB; Stevens SR; Lokhnygina Y; Halperin JL; Breithardt G; Singer DE; Mahaffey KW; Hankey GJ; Berkowitz SD; Nessel CC; Fox KA; Califf RM; Piccini JP; Patel MR;
Lancet; 2015 Jun; 385(9985):2363-70. PubMed ID: 25749644
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and Safety of Novel Oral Anticoagulants in Patients With Atrial Fibrillation and Heart Failure: A Meta-Analysis.
Savarese G; Giugliano RP; Rosano GM; McMurray J; Magnani G; Filippatos G; Dellegrottaglie S; Lund LH; Trimarco B; Perrone-Filardi P
JACC Heart Fail; 2016 Nov; 4(11):870-880. PubMed ID: 27614940
[TBL] [Abstract][Full Text] [Related]
32. Atrial fibrillation (acute).
Freestone B; Kamath S; Lip G
Clin Evid; 2003 Jun; (9):61-71. PubMed ID: 15366136
[No Abstract] [Full Text] [Related]
33. New evidence of anti-inflammatory interventions in atrial fibrillation.
Liu T; Li GP
Eur Heart J; 2006 Feb; 27(4):500; author reply 501. PubMed ID: 16361323
[No Abstract] [Full Text] [Related]
34. Multiple septal coronary-cameral fistulae associated with paroxysmal atrial fibrillation.
Işik T; Kurt M; Kaya A; Tanboğa IH
Turk Kardiyol Dern Ars; 2012 Mar; 40(2):200. PubMed ID: 22710599
[No Abstract] [Full Text] [Related]
35. Intravenous thrombolysis with recombinant tissue plasminogen activator in a stroke patient treated with apixaban.
De Smedt A; Cambron M; Nieboer K; Moens M; Van Hooff RJ; Yperzeele L; Jochmans K; De Keyser J; Brouns R
Int J Stroke; 2014 Oct; 9(7):E31. PubMed ID: 25231581
[No Abstract] [Full Text] [Related]
36. [Large studies of NOAC shows good and safe stroke protection].
Hijazi Z; Oldgren J
Lakartidningen; 2015 Sep; 112():. PubMed ID: 26348046
[No Abstract] [Full Text] [Related]
37. Atrial fibrillation (acute).
Freestone B; Lip GY
Clin Evid; 2004 Jun; (11):76-97. PubMed ID: 15652001
[No Abstract] [Full Text] [Related]
38. Atrial fibrillation (recent onset).
Lip GY
Clin Evid; 2005 Dec; (14):71-89. PubMed ID: 16620401
[No Abstract] [Full Text] [Related]
39. My wife suffers from atrial fibrillation. She is on warfarin, digoxin and metoprolol. She still gets the occasional mild attack. Is this normal?
Heart Advis; 2007 Aug; 10(8):8. PubMed ID: 18297747
[No Abstract] [Full Text] [Related]
40. Atrial fibrillation (acute).
Freestone B; Lip GY
Clin Evid; 2003 Dec; (10):76-94. PubMed ID: 15555087
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
